Its always important to weigh the potential benefits vs the risks of using any therapy, including weight loss medications
A 2024 study led by Wang, Volkow, and colleagues examined two cohorts totaling over 682,000 individuals with either obesity or type 2 diabetes and found the risk of new alcohol use disorder diagnoses was about 50% lower among those taking semaglutide compared to other anti-obesity or diabetes medications (Wang et al., 2024a)
PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this piece compares telehealth models
Purity and testing requirements High-quality sermorelin should demonstrate 98%+ purity through independent testing
Zhang Y, Wang M, Chang W (2022b) Iron dyshomeostasis and ferroptosis in alzheimers disease: molecular mechanisms of cell death and novel therapeutic drugs and targets for AD
Some report a faint sulfur-like taste from the glutathione